Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs

Metabolic dysfunction-associated steatotic liver disease (MASLD) is considered a “multisystem” disease that simultaneously suffers from metabolic diseases and hepatic steatosis. Some may develop into liver fibrosis, cirrhosis, and even hepatocellular carcinoma. Given the close connection between met...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Baoqiang, Wei, Yuankui, Zhang, Mingming, Yang, Shiyu, Tong, Rongsheng, Li, Wenyuan, Long, Enwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665502/
https://www.ncbi.nlm.nih.gov/pubmed/38027027
http://dx.doi.org/10.3389/fphar.2023.1286449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665502/
https://www.ncbi.nlm.nih.gov/pubmed/38027027
http://dx.doi.org/10.3389/fphar.2023.1286449

Ejemplares similares